Global Genome Editing Market

Genome Editing Market Size, Share, Growth Analysis, By Technology ((CRISPR)/Cas9, TALENs/MegaTALs), By Delivery Method (Ex-vivo, In-Vivo), By Application (Genetic Engineering, Clinical Applications), By Mode (Contract, In-house), By End-use (Biotechnology and pharmaceutical companies, Contract research organizations), By Region - Industry Forecast 2024-2031


Report ID: SQSG35J2001 | Region: Global | Published Date: September, 2024
Pages: 157 | Tables: 117 | Figures: 77

Genome Editing Market Insights

Global Genome Editing Market size was valued at USD 7.70 billion in 2022 and is poised to grow from USD 8.99 billion in 2023 to USD 31.15 billion by 2031, growing at a CAGR of 16.80% during the forecast period (2024-2031). 

The market is characterized by moderate merger and acquisition activity by many industry players. This is due to several factors including the desire to gain a competitive advantage in the industry. For example, in January 2024, Ginkgo Bioworks launched market that it has acquired Proof Diagnostics, expanding Ginkgo's portfolio of products into medical genetics repair tools. 

Positive government regulations on synthetic organisms, increasing demand for genes and synthetic cells, and heavy investments by governments and large corporations have driven the growth of the market. Various unconventional strategies for editing and exploiting discovered genes is an important new development in gene therapy and molecular biology. 

Large players are adopting this strategy to increase their productivity and marketability and improve their product availability in various geographies. In addition, specialized strategies to raise awareness among students and increase educational materials are expected to boost the genome editing market. For example, in March 2024 Carolina Biological Supply Company and Christianacare Gene Editing Institute worked 9 to 12 Developed exclusive CRISPR in Box educational kit for upper grades and university, offering hands-on instruction in CRISPR techniques.

US Genome Editing Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Genome Editing Market size was valued at USD 7.70 billion in 2022 and is poised to grow from USD 8.99 billion in 2023 to USD 31.15 billion by 2031, growing at a CAGR of 16.80% during the forecast period (2024-2031). 

One of the most important technical hurdles in genome editing is off-goal consequences, which encompass unintentional adjustments inside the genome. This uncertainty, mainly in the clinical applications, remains a barrier to the adoption of genome change in human medication. These unintended modifications can result in deleterious mutations, raising concerns about the safety of the genome enhancing cures. 'Merck KGaA (Germany) ', 'Cibus Inc (US) ', 'Recombinetics (US) ', 'Sangamo Therapeutics (US) ', 'Editas Medicine (US) ', 'Precision BioSciences (US) ', 'CRISPR Therapeutics (Switzerland) ', 'Intellia Therapeutics, Inc (US) ', 'Caribou Biosciences, Inc. (US) ', 'Cellectis S.A (France) ', 'AstraZeneca (UK) ', 'Takara Bio Inc. (Japan) ', 'Horizon Discovery Ltd. (Revvity, Inc.) (UK) ', 'Danaher Corporation (US) ', 'Transposagen Biopharmaceuticals, Inc. (US) ', 'Genscript Biotech Corp (China) ', 'New England Biolabs (US) ', 'OriGene Technologies, Inc. (US) ', 'bluebird bio, Inc (US) ', 'Lonza (Switzerland) ', 'Thermo Fisher Scientific Inc. (US)'

Genome editing is gaining popularity in agriculture, where it can be used to produce crops with improved traits such as drought tolerance, pest resistance and improved nutrition Agriculture is expected to play an important role in the future genome editing technological advances. CRISPR technology has improved crops rapidly in this market. 

Growing Application in Agriculture: Genome editing is gaining popularity in agriculture, where it is used to produce crops with improved traits such as drought tolerance, pest resistance and improved nutrition. CRISPR technology has enabled rapid crop improvement, which is exactly, making it a leading trend in this market. Agriculture is expected to play an important role in the future development of genome editing technologies as global food security concerns rise. 

North America is dominated the genome editing market, accounting for 47.81% in 2023 due to rising investments in R&D of gene editing technologies. Several biotechnologies and the pharmaceutical companies operating in the genome editing technology are estimated to remain dominant over the forecast period. Availability of strong research infrastructure, rise in genetically modified crops, high genetic diseases inherited diseases are common. In other words, the number of licenses issued by U.S-based firms. Increased supply has also accelerated the development of genome editing tools in the country, leading to positive market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Genome Editing Market

Report ID: SQSG35J2001

$5,300
BUY NOW GET FREE SAMPLE